AnalysisNews

CURX today

$4.60-$0.20 (-4.17%)close Nov 16, 2026

Trend

DailyDowntrend (starting)

4 hourStrong Bearish

1 hourStrong Bearish

15 minStrong Bearish

5 minConsolidating

Daily trend turns up above $149.60

Key levels

Resistance$6.80

Resistance$5.59

Support$4.38

Support$3.77

Latest news & SEC filings

EarningsCuranex Pharmaceuticals Posts Q3 2026 Results

All CURX news →

About Curanex

Curanex Pharmaceuticals is an early-stage drug developer working on plant-based medicines for inflammatory conditions. Its main candidate, Phyto-N, is a botanical extract that has been tested only in laboratory and animal studies for ulcerative colitis, atopic dermatitis, COVID-19, diabetes, fatty liver disease, and gout. The company is based in the United States and has no approved products.

Based on the company's 10-K filed Mar 30, 2026.

Nasdaq · Healthcare

Curanex Pharmaceuticals Inc (CURX)

$4.60-0.20 (-4.17%)
HOLDGrade: DRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
4.935.275.605.944.60Oct 14Oct 22Oct 30Nov 9
High4.94
Low4.60
Open4.63
Volume3K
Avg Vol12K
VWAP4.75
30d High6.27
30d Low4.60
30d Chg-7.82%

What Is the Price Target for CURX?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $4.64Upside: +0.0%Confidence: 20%Method: No Coverage

Is CURX a Buy or Sell Right Now?

32
Investability Score
HOLD12-18 months

Test your own strategy on CURX

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on CURX with SEPT’s own market data.

Start Free Trial →

Is CURX Overvalued or Undervalued?

Valuation Verdict

FAIR

Methods Used

P/B

Fair Value

$4.17

12

Moat Score

NONE

2/9

Piotroski Score

224.4

Altman Z-Score

What Is Smart Money Doing with CURX?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

CURX Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-466.67%

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for CURX

PREVIEW

Recent off-exchange (dark pool) prints for CURX: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
18:40:03$5.781,449$$8KSELL
14:40:37$5.651,105$$6KBUY
14:38:14$5.201,543$$8KBUY
18:49:48$5.001,500$$8KSELL
17:41:04$5.581,684$$9KBUY

5 dark pool trades shown · $$40K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Curanex Pharmaceuticals Inc (CURX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

CURX — frequently asked questions

What is CURX stock price today?

Curanex Pharmaceuticals Inc (CURX) is at $4.60, down 4.17% (-$0.20) at the Nov 16, 2026 close.

Why is CURX stock moving today?

Latest CURX news — Nov 14, 2026: Curanex Pharmaceuticals Posts Q3 2026 Results

Did CURX beat earnings?

CURX last reported on Aug 14, 2026: EPS -$0.60.

What are CURX support and resistance levels?

Support: $4.38, $3.77. Resistance: $5.59, $6.80, $149.60.

What are insiders doing with CURX?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on CURX?

Nov 14, 2026: Curanex Pharmaceuticals Posts Q3 2026 Results